PPARα Modulation-Based Therapy in Central Nervous System Diseases

Código QR

PPARα Modulation-Based Therapy in Central Nervous System Diseases

The burden of neurodegenerative diseases in the central nervous system (CNS) is increasing globally. There are various risk factors for the development and progression of CNS diseases, such as inflammatory responses and metabolic derangements. Thus, curing CNS diseases requires the modulation of dam...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Deokho Lee, Yohei Tomita, William Allen, Kazuo Tsubota, Kazuno Negishi, Toshihide Kurihara
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	central nervous system eye peroxisome proliferator-activated receptors Science Q
Acceso en línea:	https://doaj.org/article/26a5d7450ff5404ebf3224817d91f4c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PPAR research

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
por: Giuliana Muzio, et al.
Publicado: (2021)

Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
por: Shadi Esmaeili, et al.
Publicado: (2021)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza MA, et al.
Publicado: (2020)

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: V. S. Shirinsky, et al.
Publicado: (2017)

Nutrición molecular, papel del sistema PPAR en el metabolismo lipídico y su importancia en obesidad y diabetes mellitus: regulation of lipid metabolism by peroxisome proliferator activated receptors (PPAR). Their relatioship to obesity and diabetes mellitus
por: Uauy D,Ricardo, et al.
Publicado: (2000)

Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis
por: Wei S, et al.
Publicado: (2020)

(+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway
por: Yiyuan Xi, et al.
Publicado: (2021)

Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages
por: Ling Liang, et al.
Publicado: (2021)

Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA
por: Wan R, et al.
Publicado: (2019)

Securidaca inappendiculata-Derived Xanthones Protected Joints from Degradation in Male Rats with Collagen-Induced Arthritis by Regulating PPAR-γ Signaling
por: Zuo J, et al.
Publicado: (2021)

Nuclear Receptors in Myocardial and Cerebral Ischemia—Mechanisms of Action and Therapeutic Strategies
por: Joanna Rzemieniec, et al.
Publicado: (2021)

Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly
por: Bodh I Jugdutt
Publicado: (2010)

Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
por: Kaleigh Katzer, et al.
Publicado: (2021)

Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples
por: Brigitte Sibille, et al.
Publicado: (2021)

Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound
por: Zhijun He, et al.
Publicado: (2021)

Effect of Violet Light-Transmitting Eyeglasses on Axial Elongation in Myopic Children: A Randomized Controlled Trial
por: Kiwako Mori, et al.
Publicado: (2021)

Glucose levels between the anterior chamber of the eye and blood are correlated based on blood glucose dynamics.
por: Toshihide Kurihara, et al.
Publicado: (2021)

Development of potency assays for a plasmid containing vascular endothelial growth factor 2
por: Huang,Li-chun, et al.
Publicado: (2010)

Improved Histoarchitectural Changes with Angiotensin Receptor Blockers in Early Testicular and Cauda Toxicity in Rats
por: Faddladdeen,Khadija Abduljalil, et al.
Publicado: (2019)

Decreased, Deformed, Defective—How HIV-1 Vpu Targets Peroxisomes
por: Kristina Hopfensperger, et al.
Publicado: (2020)

The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis
por: Zaikun Xu, et al.
Publicado: (2020)

Evaluation of the role of the Endoplasmic Reticulum-Golgi transit in the biogenesis of peroxisomal membrane proteins in wild type and peroxisome biogenesis mutant CHO cells
por: TORO,ANDRÉS, et al.
Publicado: (2007)

Suppression of presbyopia progression with pirenoxine eye drops: experiments on rats and non-blinded, randomized clinical trial of efficacy
por: Yukari Tsuneyoshi, et al.
Publicado: (2017)

μ-Opioid Receptor-Mediated AT1R–TLR4 Crosstalk Promotes Microglial Activation to Modulate Blood Pressure Control in the Central Nervous System
por: Gwo-Ching Sun, et al.
Publicado: (2021)

Possible association between subtypes of dry eye disease and seasonal variation
por: Ayaki M, et al.
Publicado: (2017)

A Common 34C>G Variant at the Peroxisome Proliferator-Activated Receptor γ2- Gene in Chilean Women with Polycystic Ovary Syndrome and Controls
por: Guzmán,Neftalí, et al.
Publicado: (2007)

<named-content content-type="genus-species">Trypanosoma brucei</named-content> Pex13.2 Is an Accessory Peroxin That Functions in the Import of Peroxisome Targeting Sequence Type 2 Proteins and Localizes to Subdomains of the Glycosome
por: Logan P. Crowe, et al.
Publicado: (2020)

Edgetic Perturbations Contribute to Phenotypic Variability in PEX26 Deficiency
por: Amelie S. Lotz-Havla, et al.
Publicado: (2021)

Compartmentalization of Melanin Biosynthetic Enzymes Contributes to Self-Defense against Intermediate Compound Scytalone in <italic toggle="yes">Botrytis cinerea</italic>
por: Xue Chen, et al.
Publicado: (2021)

Dopamine, a co-regulatory component, bridges the central nervous system and the immune system
por: Mingan Li, et al.
Publicado: (2022)

The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects
por: Fatemeh Hosami, et al.
Publicado: (2021)

3-<i>O</i>-Carbamoyl-5,7,20-<i>O</i>-trimethylsilybins: Synthesis and Preliminary Antiproliferative Evaluation
por: Sitong Wu, et al.
Publicado: (2021)

Transcriptome Profiling of the Salt Stress Response in the Leaves and Roots of Halophytic Eutrema salsugineum
por: Chuanshun Li, et al.
Publicado: (2021)

CyberEye: New Eye-Tracking Interfaces for Assessment and Modulation of Cognitive Functions beyond the Brain
por: Michał Lech, et al.
Publicado: (2021)

Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
por: Li-Song Zhang, et al.
Publicado: (2012)

Endocannabinoid Metabolism and Traumatic Brain Injury
por: Dexiao Zhu, et al.
Publicado: (2021)

Autoimmune Epithelitis and Chronic Inflammation in Sjögren’s Syndrome-Related Dry Eye Disease
por: Yoko Ogawa, et al.
Publicado: (2021)

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System
por: Haofuzi Zhang, et al.
Publicado: (2021)

Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review
por: Ruchira M. Jha, et al.
Publicado: (2021)